These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29563872)

  • 1. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.
    Alves M; Beamer E; Engel T
    Front Pharmacol; 2018; 9():193. PubMed ID: 29563872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
    Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
    J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection
    Alves M; Smith J; Engel T
    Front Pharmacol; 2019; 10():1558. PubMed ID: 32009961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.
    Engel T; Smith J; Alves M
    J Inflamm Res; 2021; 14():3367-3392. PubMed ID: 34305404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
    Fischer W; Krügel U
    Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain.
    D'Alimonte I; Ciccarelli R; Di Iorio P; Nargi E; Buccella S; Giuliani P; Rathbone MP; Jiang S; Caciagli F; Ballerini P
    Int J Immunopathol Pharmacol; 2007; 20(2):301-16. PubMed ID: 17624242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2 receptors in the murine gastrointestinal tract.
    Giaroni C; Knight GE; Ruan HZ; Glass R; Bardini M; Lecchini S; Frigo G; Burnstock G
    Neuropharmacology; 2002 Dec; 43(8):1313-23. PubMed ID: 12527481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
    Resende RR; Britto LR; Ulrich H
    Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of epithelial transport via luminal P2 receptors.
    Leipziger J
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F419-32. PubMed ID: 12556361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells.
    Hervás C; Pérez-Sen R; Miras-Portugal MT
    J Neurosci Res; 2003 Aug; 73(3):384-99. PubMed ID: 12868072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of acid-sensing ion channel activity by metabotropic P2Y UTP receptors in primary sensory neurons.
    Ren C; Gan X; Wu J; Qiu CY; Hu WP
    Purinergic Signal; 2016 Mar; 12(1):69-78. PubMed ID: 26538146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
    Fumagalli M; Brambilla R; D'Ambrosi N; Volonté C; Matteoli M; Verderio C; Abbracchio MP
    Glia; 2003 Sep; 43(3):218-03. PubMed ID: 12898701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.